Steward Partners Investment Advisory’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-29
Closed -$334 – 4280
2025
Q2
$334 Hold
29
– – ﹤0.01% 3999
2025
Q1
$435 Hold
29
– – ﹤0.01% 3869
2024
Q4
$502 Buy
+29
New +$560 ﹤0.01% 3851
2020
Q4
– Sell
-27
Closed – – 2890
2020
Q3
$0 Hold
27
– – ﹤0.01% 2748
2020
Q2
$1K Hold
27
– – ﹤0.01% 2545
2020
Q1
$0 Sell
27
-101
-79% -$2.83K ﹤0.01% 2512
2019
Q4
$4K Hold
128
– – ﹤0.01% 2287
2019
Q3
$5K Sell
128
-5
-4% -$232 ﹤0.01% 2230
2019
Q2
$6K Buy
+133
New +$7.8K ﹤0.01% 2150
2018
Q4
– Sell
-155
Closed -$18K – 990
2018
Q3
$18K Buy
155
+92
+146% +$10.4K ﹤0.01% 1598
2018
Q2
$8K Buy
63
+27
+75% +$3.29K ﹤0.01% 1806
2018
Q1
$3K Buy
+36
New +$3.98K ﹤0.01% 1904

Other funds holding CLB

Steward Partners Investment Advisory's CLB Position: Q3 2025 in Review

Steward Partners Investment Advisory sold out of Core Laboratories (CLB) in Q3 2025, closing a stake of 29 shares — an estimated $334 sold.

Steward Partners Investment Advisory first reported a position in CLB in Q1 2018 and held it in 12 quarters. The position peaked at $18K in Q3 2018. 190 funds tracked by Wall St. Rank hold CLB as of Q3 2025.

  • Steward Partners Investment Advisory reported no remaining Core Laboratories position as of Q3 2025 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 29 Core Laboratories shares in Q3 2025, an estimated $334.
  • Steward Partners Investment Advisory first reported a position in Core Laboratories in Q1 2018 and held it in 12 quarters.
  • Steward Partners Investment Advisory's Core Laboratories position peaked at $18K in Q3 2018.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2025.

Based on Steward Partners Investment Advisory's 13F filing for Q3 2025, filed 12 Nov 2025.